Valeant Pharmaceuticals sales and marketing update

Valeant’s Sprout Pharmaceuticals Inc. division launched Addyi flibanserin in the U.S. to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. The wholesale ac...